Russell Investments Group Ltd. Lowers Stake in CIGNA Co. (CI)

Russell Investments Group Ltd. cut its stake in shares of CIGNA Co. (NYSE:CI) by 7.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 931,947 shares of the health services provider’s stock after selling 80,094 shares during the period. Russell Investments Group Ltd. owned 0.38% of CIGNA worth $193,294,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Pennsylvania Trust Co lifted its holdings in shares of CIGNA by 1.2% during the 3rd quarter. Pennsylvania Trust Co now owns 20,363 shares of the health services provider’s stock valued at $4,241,000 after acquiring an additional 245 shares in the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in shares of CIGNA by 8.7% during the 3rd quarter. Steward Partners Investment Advisory LLC now owns 3,662 shares of the health services provider’s stock valued at $763,000 after acquiring an additional 292 shares in the last quarter. Huntington National Bank lifted its holdings in shares of CIGNA by 22.2% during the 2nd quarter. Huntington National Bank now owns 1,617 shares of the health services provider’s stock valued at $275,000 after acquiring an additional 294 shares in the last quarter. Boston Financial Mangement LLC lifted its holdings in shares of CIGNA by 15.8% during the 2nd quarter. Boston Financial Mangement LLC now owns 2,315 shares of the health services provider’s stock valued at $393,000 after acquiring an additional 315 shares in the last quarter. Finally, Burney Co. lifted its holdings in shares of CIGNA by 1.5% during the 2nd quarter. Burney Co. now owns 21,718 shares of the health services provider’s stock valued at $3,691,000 after acquiring an additional 318 shares in the last quarter. 89.42% of the stock is owned by institutional investors.

Shares of CIGNA stock traded down $2.20 during trading on Friday, reaching $208.17. The company had a trading volume of 62,535 shares, compared to its average volume of 2,343,385. The firm has a market cap of $50.81 billion, a PE ratio of 19.72, a price-to-earnings-growth ratio of 1.23 and a beta of 0.64. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.38 and a current ratio of 0.38. CIGNA Co. has a fifty-two week low of $163.02 and a fifty-two week high of $227.13.



CIGNA (NYSE:CI) last issued its earnings results on Thursday, August 2nd. The health services provider reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.33 by $0.56. The business had revenue of $11.50 billion for the quarter, compared to analyst estimates of $11.20 billion. CIGNA had a net margin of 5.82% and a return on equity of 22.27%. The company’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.91 EPS. On average, equities analysts predict that CIGNA Co. will post 13.87 earnings per share for the current year.

In other CIGNA news, CFO Eric P. Palmer acquired 2,828 shares of the stock in a transaction that occurred on Tuesday, July 31st. The stock was acquired at an average price of $177.61 per share, with a total value of $502,281.08. Following the transaction, the chief financial officer now directly owns 9,678 shares in the company, valued at $1,718,909.58. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director William D. Zollars sold 238 shares of the business’s stock in a transaction dated Friday, September 14th. The shares were sold at an average price of $193.70, for a total transaction of $46,100.60. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

A number of equities analysts have commented on the stock. Zacks Investment Research lowered shares of CIGNA from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 9th. Leerink Swann boosted their price objective on shares of CIGNA from $235.00 to $250.00 and gave the stock an “outperform” rating in a report on Friday, September 21st. SunTrust Banks boosted their price objective on shares of CIGNA to $244.00 and gave the stock a “buy” rating in a report on Friday, August 3rd. Credit Suisse Group boosted their price objective on shares of CIGNA from $223.00 to $237.00 and gave the stock an “outperform” rating in a report on Tuesday, September 18th. Finally, ValuEngine upgraded shares of CIGNA from a “sell” rating to a “hold” rating in a report on Friday, August 3rd. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $231.14.

About CIGNA

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Story: Return on Investment (ROI) Defined, Explained

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply